About Quotient Biodiagnostics
Quotient Biodiagnostics is a company based in Newtown Square (United States) founded in 2008.. Quotient Biodiagnostics has raised $16.2 million across 7 funding rounds from investors including Galen Partners. The company has 178 employees as of March 31, 2022. Quotient Biodiagnostics offers products and services including MosaiQ, Alba, and LumiQ. Quotient Biodiagnostics operates in a competitive market with competitors including HORIBA, Boule Diagnostics, Entia, FYR Diagnostics and Mursla, among others.
- Headquarter Newtown Square, United States
- Employees 178 as on 31 Mar, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alivedx Suisse S.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.2 M (USD)
in 7 rounds
-
Latest Funding Round
$36 M (USD), Debt – Conventional
Jun 29, 2018
- Investors
-
Employee Count
178
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quotient Biodiagnostics
Quotient Biodiagnostics offers a comprehensive portfolio of products and services, including MosaiQ, Alba, and LumiQ. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Multiplex platform for faster in-vitro diagnostic results in labs.
Manual reagents for blood bank and immunohematology applications.
All-in-one system for autoimmune testing and lab efficiency.
Unlock access to complete
Unlock access to complete
Funding Insights of Quotient Biodiagnostics
Quotient Biodiagnostics has successfully raised a total of $16.2M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $36 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $36.0M
-
First Round
First Round
(05 Mar 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Debt – Conventional - Quotient Biodiagnostics | Valuation |
investors |
|
| Nov, 2017 | Amount | Post-IPO - Quotient Biodiagnostics | Valuation |
investors |
|
| Oct, 2016 | Amount | Debt – Conventional - Quotient Biodiagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quotient Biodiagnostics
Quotient Biodiagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Galen Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quotient Biodiagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Quotient Biodiagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quotient Biodiagnostics Comparisons
Competitors of Quotient Biodiagnostics
Quotient Biodiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HORIBA, Boule Diagnostics, Entia, FYR Diagnostics and Mursla, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multinational conglomerate
|
|
| domain | founded_year | HQ Location |
Provider of blood count analyzer for human and veterinary applications
|
|
| domain | founded_year | HQ Location |
Point-of-care devices for blood analysis are developed and provided.
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostic tests for disease detection are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic devices for cancer detection are developed using nanostructures.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quotient Biodiagnostics
Frequently Asked Questions about Quotient Biodiagnostics
When was Quotient Biodiagnostics founded?
Quotient Biodiagnostics was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is Quotient Biodiagnostics located?
Quotient Biodiagnostics is headquartered in Newtown Square, United States. It is registered at Newtown Square, Pennsylvania, United States.
Is Quotient Biodiagnostics a funded company?
Quotient Biodiagnostics is a funded company, having raised a total of $16.2M across 7 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $84M, raised on Mar 05, 2012.
How many employees does Quotient Biodiagnostics have?
As of Mar 31, 2022, the latest employee count at Quotient Biodiagnostics is 178.
What does Quotient Biodiagnostics do?
Manufacturer of immunohematology products for use in transfusion diagnostics. It focused on providing immunohematology products to hospitals and blood banks. Through its wholly-owned subsidiary, Alba Bioscience, Quotient offers research, development, and manufacturing of transfusion diagnostics products that traditionally have been sold worldwide either directly or by other major transfusion companies. It offers MosaiQ by Quotient, a comprehensive automation solution for blood grouping (for patients and donors) and donor disease screening.
Who are the top competitors of Quotient Biodiagnostics?
Quotient Biodiagnostics's top competitors include HORIBA, Entia and Boule Diagnostics.
What products or services does Quotient Biodiagnostics offer?
Quotient Biodiagnostics offers MosaiQ, Alba, and LumiQ.
Who are Quotient Biodiagnostics's investors?
Quotient Biodiagnostics has 1 investor. Key investors include Galen Partners.